TrialCancer science2022

Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes.

Yasunori Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.